Please wait while we load the requested 6-K report or click the link below:
https://last10k.com/sec-filings/report/1702123/000106299322007701/form6k.htm
April 2024
February 2024
February 2024
February 2024
January 2024
January 2024
December 2023
November 2023
November 2023
November 2023
Please wait while we load the requested 6-K report or click the link below:
https://last10k.com/sec-filings/report/1702123/000106299322007701/form6k.htm
Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Cardiol Therapeutics Inc..
Cardiol Therapeutics Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
Cardiol Therapeutics Inc. provided additional information to their SEC Filing as exhibits
Ticker: CRDL
CIK: 1702123
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001062993-22-007701
Submitted to the SEC: Tue Mar 15 2022 7:28:22 AM EST
Accepted by the SEC: Tue Mar 15 2022
Period: Tuesday, March 15, 2022
Industry: Biological Products No Disgnostic Substances